Latest Cord blood bank Stories

Cryo-Cell Reports Financial Results for Fiscal 2011

2012-02-29 12:45:00

OLDSMAR, Fla., Feb. 29, 2012 /PRNewswire/ -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, today announced results for its fiscal year 2011. "Cryo-Cell fiscal 2011 results are indicative of a company that is in the process of making many organizational and operational improvements," stated David Portnoy, Cryo-Cell's Chairman and Co-CEO. "Although the...

The First and Only Cord Blood Laboratory in Miami Florida Announces Today the Implementation of a Cord Blood Workshop

2012-02-24 20:00:00

GeneCell International Launches Educational Cord Blood Workshops for South Florida Expecting Parents Miami, FL. (PRWEB) February 24, 2012 GeneCell International, a cutting-edge South Florida provider in the processing and cryogenic preservation of umbilical cord blood stem cells, announced today it would commence monthly cord blood workshops to advance the education in the community. GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult...

GeneCell International’s Director of Research and Laboratory Operations is Invited to Speak at a Local Middle School in Miami, FL

2012-02-23 00:00:00

Dr. Todd Flower, Director of Research and Laboratory Operations at GeneCell International, has been invited to speak at the Jorge Mas Canosa Middle School on career day to a group of students about the science behind adult stem cells. Miami, FL. (PRWEB) February 22, 2012 Dr. Todd Flower, Director of Research and Laboratory Operations at GeneCell International, has been invited to speak at the Jorge Mas Canosa Middle School on career day to a group of students about the science behind...

Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION

2012-02-17 05:00:00

BOTHELL, Wash., Feb. 17, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, today announced that TRANSFUSION, the foremost publication in the world for new information regarding transfusion medicine, has published a peer-reviewed journal article reporting positive results of collaborative research on CryoStor®, BioLife's...

Howard P. Milstein, Chair of New York Blood Center (NYBC), Joins in Honoring Latest Additions to FDNY "Honor Roll of Life"

2012-02-08 13:02:00

NEW YORK, Feb. 8, 2012 /PRNewswire/ -- At a late January ceremony at New York City Fire Department headquarters in downtown Brooklyn, Howard P. Milstein, chair of the New York Blood Center (NYBC), joined Fire Commissioner Salvatore J. Cassano and Christopher D. Hillyer, M.D., President and CEO of NYBC, to add the names of six 2011 FDNY bone marrow donors to NYBC's "Honor Roll of Life." (Photo: http://photos.prnewswire.com/prnh/20120208/NY50108-a )(Photo:...

ResearchMoz: Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report 2012

2012-02-08 03:30:00

ALBANY, New York, February 8, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012 [http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html ] This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report,...

Cryo-Cell International, Inc. Announces Material Transfer Agreement with Stanford University

2012-02-07 08:00:00

Collaboration will evaluate menstrual stem cells for future potential diabetes therapy Oldsmar, Fla (PRWEB) February 07, 2012 Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) and Stanford University announced signing a material transfer agreement to test the efficacy of mesenchymal-like stem cells derived from menstrual blood (MenSCs) in a model of pancreatic islet transplantation for type 1 diabetes treatment. Specifically, the menstrual blood stem cells provided by...

Independent Data Published on BioLife Solutions HypoThermosol® and CryoStor®

2012-01-27 05:00:00

BOTHELL, Wash., Jan. 27, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells and tissues, today announced that several groups of independent researchers have reported superior biopreservation efficacy using the Company's proprietary cGMP grade HypoThermosol storage/shipping medium and CryoStor cryopreservation freeze media. (Logo:...

Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System

2012-01-23 08:00:00

RANCHO CORDOVA, Calif., Jan. 23, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today, it had received an initial order for its BioArchive(®) System from a new public cord blood bank that will begin operations in Canada in early 2013. Canadian Blood Services, a national charitable organization that manages the supply of blood and blood products in all Canadian provinces...

First FDA-Approved Study of Stem Cells to Treat Hearing Loss Begins at Children's Memorial Hermann Hospital

2012-01-12 10:05:00

HOUSTON, Jan. 12, 2012 /PRNewswire/ -- Children's Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss. To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss (Logo:...